2nd Annual Anti-Fibrotic Drug Development (AFDD) Summit
In-Person Event
Nov 27 - 29, 2018
Cambridge, Massachusetts, USA
OVERVIEW
2nd Annual Anti-Fibrotic Drug Development (AFDD) Summit is organized by Hanson Wade and will be held from Nov 27 - 29, 2018 at Hyatt Regency Cambridge, Overlooking Boston, Cambridge, Massachusetts, United States of America. The target audience for this medical event is drug developers focused on organ-specific fibrotic indications.
Conference Description:
This Summit fills the gap as the only industry-dedicated forum for drug developers focused on organ-specific indications to participate in cross-disciplinary, multi-organ discussion and take away new insights into anti-fibrotic drug development research including:
• Mechanisms of action and new targets for emerging candidates; alongside updates on leading advancements targeting integrins and TGF?
• Innovations in preclinical modalities to improve the clinical relevance of engineered in vitro tissues and recapitulation of human disease in vivo
• Applying genomics to inform the clinical trial design and better understand population heterogeneity.
Built from research with 20 of the leading experts in immuno-inflammation and fibrosis; the summit will enable you to evaluate key challenges in translating fibrotic mechanisms into clinically effective therapeutics with a tighter lens.
Additional details will be posted as soon as they are available.
Conference Description:
This Summit fills the gap as the only industry-dedicated forum for drug developers focused on organ-specific indications to participate in cross-disciplinary, multi-organ discussion and take away new insights into anti-fibrotic drug development research including:
• Mechanisms of action and new targets for emerging candidates; alongside updates on leading advancements targeting integrins and TGF?
• Innovations in preclinical modalities to improve the clinical relevance of engineered in vitro tissues and recapitulation of human disease in vivo
• Applying genomics to inform the clinical trial design and better understand population heterogeneity.
Built from research with 20 of the leading experts in immuno-inflammation and fibrosis; the summit will enable you to evaluate key challenges in translating fibrotic mechanisms into clinically effective therapeutics with a tighter lens.
Additional details will be posted as soon as they are available.
KEY DATES
27 Nov, 2018
Event Start Date
29 Nov, 2018
Event End Date
SPECIALITIES
Health InformaticsPharmacy and MedicineSUGGESTED HOTELS
CONFERENCE VENUE
Hyatt Regency Cambridge, Overlooking BostonRELATED CONFERENCES & LIVE WEBINARS
Quick Links